Sri Lanka, July 15 -- The Cabinet has granted approval for the procurement of 400,000 vials of Desferrioxamine Mesylate Injection BP 500 mg, a critical medication used to treat patients with anemia and thalassemia by removing excess iron from the body.

The purchase was initiated through the International Competitive Bidding (ICB) process, with two companies submitting bids. Following an evaluation by the High-Level Standing Procurement Committee, M/s. ABC Pharma Services (Pvt) Ltd. of Sri Lanka was identified as the only responsive bidder.

Based on this recommendation, the Cabinet approved the proposal presented by the Minister of Health and Mass Media to award the procurement to the Ministry of Health and Mass Media, ensuring continued...